Related Experiment Video
Updated: Jul 15, 2025

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Novel Biomarkers and Imaging Indices for the "Vulnerable Patient" with Carotid Stenosis: A Single-Center Study
Nikolaos Kadoglou1, Konstantinos G Moulakakis2, George Mantas3
1Medical School, University of Cyprus, 2029 Nicosia, Cyprus.
Insights
Matrix metalloproteinases (MMPs), cardio-ankle vascular index (CAVI), and Gray-Scale Median (GSM) score predict major adverse cardiovascular events (MACE) after carotid revascularization. These biomarkers identify vulnerable patients at risk for future cardiovascular events.
Area of Science:
- Vascular Biology and Cardiovascular Medicine
- Biomarkers and Diagnostic Imaging
- Clinical Atherosclerosis Research
Background:
- Carotid atherosclerosis poses a significant risk for major adverse cardiovascular events (MACE).
- Identifying vulnerable plaque and predicting MACE after carotid revascularization remains a clinical challenge.
- Matrix metalloproteinases (MMPs), cardio-ankle vascular index (CAVI), and Gray-Scale Median (GSM) score are potential indicators of atherosclerosis severity and vulnerability.
Purpose of the Study:
- To investigate the association of MMPs, CAVI, and GSM with carotid atherosclerosis severity and vulnerability.
- To determine the predictive value of these biomarkers for MACE following carotid artery revascularization.
- To identify novel imaging and biochemical markers for stratifying MACE risk in patients undergoing carotid revascularization.
Main Methods:
- A cohort study involving 262 patients undergoing carotid revascularization therapy (GRT), 109 asymptomatic patients with low-grade stenosis (GCT), and 92 controls (GCO).
- Baseline assessments included clinical parameters, metabolic profile, CAVI, GSM, and serum levels of hsCRP, MMP-3, -7, -9, and TIMP-1.
- Follow-up averaged 55 months to ascertain MACE occurrences.
Main Results:
- Elevated CAVI, MMPs, and TIMP-1 levels were observed in both GRT and GCT groups compared to GCO (p < 0.001).
- Higher levels correlated with symptomatic disease or greater stenosis degree (p < 0.001).
- In GRT patients, diabetes, smoking, high CAVI, elevated MMP-9, and low GSM independently predicted MACE (p < 0.05), despite optimal medical therapy.
Conclusions:
- Novel imaging and biochemical biomarkers are linked to atherosclerosis severity.
- CAVI, MMP-9, and low GSM independently predict MACE after carotid revascularization.
- These markers help identify "vulnerable patients" at higher risk for cardiovascular events.
Background:
We investigated the relationship of matrix metalloproteinases (MMPs), cardio-ankle vascular index (CAVI), and Gray-Scale Median (GSM) score with the severity and vulnerability of carotid atherosclerosis and major adverse cardiovascular events (MACE) during follow-up of carotid artery revascularization.
Methods:
We enrolled 262 patients undergoing carotid revascularization therapy (GRT), 109 asymptomatic patients with low-grade carotid stenosis (40-70%) receiving conservative treatment (GCT), and 92 age- and sex-matched control subjects without carotid atherosclerosis (GCO). All participants underwent carotid ultrasound and we assessed at baseline clinical parameters, metabolic profile, CAVI, GSM, and circulating levels of hsCRP, MMP-3,-7,-9, and TIMP-1.
Results:
Both GRT and GCT presented with elevated CAVI, MMPs, and TIMP-1 levels compared to GCO (p < 0.001). The escalation highly correlated to the presence of symptoms or paralleled the degree of carotid stenosis (p < 0.001). During follow-up (mean duration: 55 months), 51 GRT patients experienced MACE unrelated to the revascularization procedure. Within GRT, diabetes (HR: 2.07; CI: 1.55-2.78, p < 0.001), smoking (HR: 1.67; CI: 1.35-1.95, p < 0.001), high CAVI (HR: 1.22; CI: 1.09-1.43, p = 0.023) and MMP-9 (HR: 1.44; CI: 1.29-2.15, p = 0.005), and low GSM (HR: 1.40; CI: 1.16-2.12, p = 0.002) independently predicted MACE occurrences, despite the optimum medical therapy.
Conclusions:
Novel imaging and biochemical biomarkers were positively associated with atherosclerosis severity, while CAVI, MMP-9, and low GSM showed a positive, independent relationship with MACE after carotid revascularization, describing "vulnerable patients".
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies VII: Vascular Imaging
Aneurysm II: Clinical Manifestations and Diagnostic Studies

